Drug Side Effects Index: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z


HEP B (ENGERIX-B)

HEP B (ENGERIX-B)
Learn about HEP B (ENGERIX-B) serious adverse events reported to Food and Drug Administration (FDA).
Total reports: 330
Reported hospitalizations: 110      Reported deaths: 5 ………………………………………………………………………………………………

< Previous  Showing 61-90 of 330 Next >

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from MI, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a nurse and described the occurrence of anaphylactic reaction in a 17 year old female subject who received hepatitis B vaccine recombinant (Engerix B). On an unspecified date in March 2005 on or before March 28 2005, the subject received the first dose of Engerix B in the left arm (lot AHBV0077AB). At an unspecified time following the first dose of Engerix B, on March 28 2005, the subject experienced soreness, redness, tingling and a rash covering the entire arm. The subject was di. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient, 44 years of age, was vaccinated with HEP B (ENGERIX-B) on Mar 2005, 23. This case was reported by a consumer and described the occurrence of an injection site reaction in a 44 year old female patient who received hepatitis B vaccine recombinant (Engerix B). The reporter is the patient. A physician or other health care professional has not verified this report. The patients past medical history included allergy to norflex, codeine and bismuth subsalicylate. On 2/25/2005, the patient received the first dose of Engerix B. On 3/23/2005, the patient received the second dose of Enger.Paient has the following illness history - Allergy of Norflex, codeine allergy, the patient is allergic to bismuth subsalicylate. The patients concurrent conditions were not reported..Patient was taken to emergency room. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from IN, USA. Female patient, 21 years of age, was vaccinated with HEP B (ENGERIX-B) on Mar 2005, 29. This case was reported by a nurse and described the occurrence of hives in a 21 year old male patient who received hepatitis B vaccine recombinant Engerix B. The patient had no pre existing medical conditions. On 3/29/2005, the patient received the first dose of Engerix B (lot AHBVA059BA) in the right deltoid. Approximately six days following the first dose of Engerix B, on 4/4/2005, the patient experienced hives and itching. The hives and itching improved on 4/6/2005. The immunization series with Engerix B.Paient has the following illness history - The patient had no pre existing medical conditions. The patient's concurrent conditions were not reported.. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from KS, USA. Female patient, 57 years of age, was vaccinated with HEP B (ENGERIX-B) on Mar 2005, 01. This case was reported by a nurse and described a 57 year old female patient who did not respond to immunization with hepatitis B vaccine recombinant Engerix B. On Jan 15 2004, the patient received the 1st dose of Engerix B. On 2/15/2004, the patient received second dose of Engerix B. On 9 21/2004, the patient received the third dose of Engerix B. This is longer than the recommended interval of six months between the first and third doses of Engerix B. On an unspecified date after 9/21/2004 and before 10/28.Patient was taken to emergency room. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from KS, USA. Female patient, 54 years of age, was vaccinated with HEP B (ENGERIX-B) on Oct 2004, 25. This case was reported by a nurse and described a 54 year old patient who did not respond to immunization with hepatitis B vaccine recombinant (Engerix B). On 04/22/2004, the patient received the first dose of Engerix B (lot ENG5553B2). On 04/25/2004, the patient received the second dose of Engerix B (lot ENG5553B) On 10/25/2004 the patient received the third dose of Engerix B. On an unspecified date after 10/25/2004 and on or before April 7 2005, a hepatitis B surface antibody titer was negative.. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from KS, USA. Female patient, 45 years of age, was vaccinated with HEP B (ENGERIX-B) on Oct 2004, 24. This case was reported by a nurse and described a 45 year old male patient who did not respond to immunization with hepatitis B vaccine recombinant (Engerix B). On 04/22/2004, the patient received the first dose of Engerix B (lot ENG5553B2). On 05/24/2004, the patient received the second dose of Engerix B (lot ENG5520A2) On 10/24/2004 the patient received the third dose of Engerix B (lot number not provided). On an unspecified date after 10/24/2004 and on or before April 7 2005, a hepatitis B surface antib.Patient was taken to emergency room. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a nurse and described a patient who did not respond to immunization with hepatitis B vaccine recombinant (Engerix B). On an unspecified date, the patient received the third dose of Engerix B (lot AHBV032AA incorrect lot number). At an unspecified time following the third dose of Engerix B. on Feb 18 2005, a hepatitis B surface antibody titer was negative. On March 2 2005, the patient received the fourth dose of Engerix B (lot AHBV032AA incorrect lot number). Approximately 30 days a.Patient was taken to emergency room. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a pharmacy technician and described the occurrence of an injection site reaction in a male patient who received hepatitis B vaccine recombinant (Engerix B). On an unspecified date on or before 04/08/2005, the patient received a dose of Engerix B (dose number, lot number, and site of administration not provided). At an unspecified time following the administration of Engerix B, on or before 4/8/2005, the patient experienced an injection site reaction. The outcome of the injection si. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from CA, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a pharmacist and described the occurrence of an injection site reaction in an adult patient who received hepatitis B vaccine recombinant (Engerix B). The physician reported that multiple patients experienced injection site reactions with Engerix B, however patient identifiers were not provided. On an unspecified date on or before 4/13/2005, the patient received a dose of Engerix B into the deltoid muscle (dose number not provided, lot AHBVB034BB). the pharmacist referred to the Eng. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a nurse and described a patient who did not respond to immunization with hepatitis B vaccine recombinant (Engerix B). On an unspecified date, the patient received the sixth dose of hepatitis B vaccine (manufacture unknown). Subsequently, on an unspecified date on or before 05/02/2005, a hepatitis B surface antibody titer was negative.. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from NH, USA. Female patient, child 00 years of age, was vaccinated with HEP B (ENGERIX-B) on Jan 2002, 17. This case was reported by a medical assistant and described the occurrence of seizure in a 2 day old male subject who was vaccinated with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. On Jan 17 2002, the subject received 1st dose of Engerix B (lot ENG5252A2). At an unspecified time after vaccination with Engerix B, on or after 01/17/2002 an don or before May 4 2005, the subject experienced seizure. The outcome of the seizure was not reported. Comment: seizure was assessed as medically serious. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from VA, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a physician and described the occurrence of an unspecified illness in a child of unspecified gender who was vaccinated with hepatitis B vaccine recombinant (Engerix B) for prophylaxis. On an unspecified date on or before May 12 2005, the subject received a dose of Engerix B (dose number nor provided, lot ENG5224B9). The physician reported that, at an unspecified period of time following the administration of Engerix B, on an unspecified date on or before May 12 2005, the subject be. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from NY, USA. Female patient was vaccinated with HEP B (ENGERIX-B) on May 2005, 06. This case was reported by a physician and described the occurrence of rash under eyes in a 3 week old subject of female who was vaccinated with hepatitis B vaccine recombinant Engerix B for prophylaxis. The subject had no known allergies. Concurrently the subject received no medications. On May 6 2005, the subject received the 1st dose of Engerix B. On may 12 2005, 6 days after vaccination with Engerix B, the patient experienced an allergic reaction manifested as a rash beneath the eyes and was seen at a ph.Paient has the following illness history - The patient's had no known allergies. The subjects concurrent conditions were not reported..Patient was taken to emergency room. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a pharmacist and described an adult subject of unspecified gender who had a decreased response to vaccination with hepatitis B vaccine recombinant Engerix B, for prophylaxis. the pharmacist states that, four nurses, had a decreased response to vaccination with Engerix B, however patient identifiers were not provided. The pharmacist reported that she, believes that the nurses were probably overweight, smokers and of ethnic origin. On an unspecified date before May 13 2005, the subje. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from CA, USA. Female patient, 40 years of age, was vaccinated with HEP B (ENGERIX-B) on Jan 1998, 14. This case was reported by a nurse and described the occurrence of arthritis in a 40 year old female subject who was vaccinated with hepatitis b vaccine recombinant Engerix B for prophylaxis. The reporter is the patient. The nurse reported that several other subjects experienced similar problems following the administration of Engerix B, however, no identifiers were provided. Medical history was notable for a finger stick in 1997. On 9/1/1994, the subject received first dose of Engerix B. On 10/24/1994, the. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from OH, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a nurse and described an adult male patient who did not respond to immunization with hepatitis B recombinant (Engerix-B). Medical history included HIV positive. On unspecified dates, the patient received "two series" of Engerix-B (lot number not provided). Subsequently, on an unspecified date in 2005, a hepatitis B surface antibody titer was "Negative.". Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from VA, USA. Female patient, 26 years of age, was vaccinated with HEP B (ENGERIX-B) on May 2005, 01. This case was reported by a consumer and described the occurrence of dizziness in a 26 year old female subject who was vaccinated with hepatitis B vaccine recombinant (Engerix-B) for prophylaxis. The reporter is the mother of the subject. A physician or other health care professional has not verified this report. Concurrent medical conditions included family history of Multiple Sclerosis (mother). On an unspecified date in May 2005, the subject received the first dose of Engerix-B (lot number not specified).Paient has the following illness history - Family History of Multiple Sclerosis. The patient has no medical history of diabetes or low blood sugar, and does not test for blood glucose values. The patient's mother has a history of Multiple Sclerosis. The patient's concurrent conditio. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from RI, USA. Female patient, 56 years of age, was vaccinated with HEP B (ENGERIX-B) on Sept 2004, 10. This case was reported by a health professional and described a 57 year old female subject who did not respond to immunization with hepatitis B vaccine recombinant Engerix B. Medical history included breast cancer, fatigue, muscle spasms, allergy to sulfa, and social alcohol use. Concurrent medications included tamoxifen to treat breast cancer, modafinil (Provigil) to treat fatigue and baclofen to treat muscle spasms. On 3/10/2004, 4/09/2004, and 09/10/2004, the subject received three doses of Engerix B (lo.Paient has the following illness history - Breast Cancer, fatigue, muscle spasm, social alcohol drinker, sulfa allergy. The nurse also reported one additional patient who did not respond to immunization with Engerix B see A0562695A..Patient was receiving Tamoxifen citrate, Modafinil, Baclofen.. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from RI, USA. Female patient, 28 years of age, was vaccinated with HEP B (ENGERIX-B) on Sept 2004, 17. This case was reported by a health professional and described a 28 year old female subject who did not respond to immunization with hepatitis B vaccine recombinant Engerix B. The subjects medical history included allergy to erythromycin, asthma, gastroesophageal reflux disease, tobacco use, and social drinking. Concurrent medication included fluticasone propionate + salmeterol xinafoate (Advair) to treat asthma, esomeprazole (Nexium) to treat gastroesophageal reflux disease, and zolpidem (Ambien) for an uns.Paient has the following illness history - Allergy to erythromycin, asthma, gastroesophageal reflux disease, smoker, social alcohol drinker. The nurse also reported on additional patient who did not respond to immunization with Engerix B S A0562674A..Patient was receiving Fluticasone salmeterol, Esomeprazole, Zolpidem tartrate.. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from CA, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a physician and described an adult patient who did not respond to immunization with hepatitis B recombinant vaccine (Engerix-B) immunization series. The physician state that "some" patients did not respond to immunization with Engerix-B; however no patient identifiers were available. Medical history included HIV. The patient's concurrent conditions and concurrent medications were not reported. On unspecified dates, the patient received three doses of Engerix-B (lot number not speci. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a pharmacist and described an adult patient who did not respond to the hepatitis B vaccine recombinant (Engerix-B) immunization series. The patient's medical history, concurrent medical conditions, and concurrent medications were not reported. On unspecified dates, the patient received "a series" (three separate doses) of Engerix-B (lot number not specified). On an unspecified date following the third dose of Engerix-B, a hepatitis B surface antibody titer showed the patient "did n. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a pharmacist and described the occurrence of an unspecified adverse event in a subject of unspecified age and gender who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. On an unspecified date several years ago the subject received unspecified dose of Engerix-B. The pharmacist reported that "a physician mentioned to me that at an unspecified time after vaccination with Engerix B, the subject, he thinks, had a reaction to it (Engerix-B)".. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a health professional and described a patient of unspecified age and gender who did not respond to immunization with hepatitis B recombinant vaccine (Engerix-B) immunization series. The health professional stated that seven or eight patients did not respond to immunization with Engerix-B; however no patient identifiers were available. On unspecified dates, the patient received 3 doses of Engerix-B. Subsequently, on an unspecified date later, a hepatitis B surface antibody titer i. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from NJ, USA. Female patient, 34 years of age, was vaccinated with HEP B (ENGERIX-B) on June 2005, 20. This case was reported by a physician and described the occurrence of rash in a 34 year old female subject who was vaccinated with hepatitis B vaccine recombinant for prophylaxis. Concurrent medical conditions included allergy to erythromycin and eczema. Concurrent medications included Multivitamins for dietary supplementation and Pseudoephedrine hydrochloride for an unspecified medical condition. On 06/20/2005 the subject received the 1st dose of Engerix-B in the left arm. On 06/21/2005, 1 day after vac.Paient has the following illness history - Allergy to Erythromycin.Patient was receiving Multivitamin, Pseudoephedrine HCL.Patient was taken to emergency room. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from IN, USA. Female patient, 41 years of age, was vaccinated with HEP B (ENGERIX-B) on June 2005, 24. This case was reported by a pharmacist and described a 41 year old male patient who inadvertently received Hepatitis B vaccine recombinant that was stored above the recommended temperature. Medical history included smoker. The patient's concurrent conditions, and concurrent medications were not reported. On 08/12/1992, the patient received the third dose of hepatitis B vaccine. Approximately 13 years later, on 06/13/2005, a hepatitis B surface antibody titer measured less than 3.0 ml. On 06/24/2005, th. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from , USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a nurse and described a 56 year old female subject who did not respond to immunization with Hepatitis B vaccine recombinant. The subject's medical history included no known allergies. On an unspecified date in December 2004, the subject received the third dose of Engerix-B. At an unspecified time following the administration of the third dose of Engerix-B, on or after December 2004 and on or before 06/27/2005, a hepatitis B surface antibody test revealed a titer of less than fiv. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from FL, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a physician and described a subject of unspecified age and gender who had a decreased response to immunization with hepatitis B vaccine recombinant Engerix B. The physician reported that an unspecified number of patients experienced a decrease response to Engerix B, however, no subject identifies were provided. Medical history included human immunodeficiency virus infection. On an unspecified date before June 29 2005, the subject received a dose of Engerix B (dose number not provid. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from NJ, USA. Female patient, child 00.7 years of age, was vaccinated with HEP B (ENGERIX-B) on Dec 1996, 09. This case was reported by a nurse and described the occurrence of pervasive developmental disorder in a 2 year old male subject who was vaccinated with hepatitis B vaccine recombinant Engerix B for prophylaxis. This report was initially received via manufacturer research. On 3/29/1996, the subject received the first dose of hepatitis B vaccine unknown manufacturer. On 5/10/1996, the subject received the second dose of hepatitis B vaccine recombinant Engerix B (lot ENG2004A2). Approximately nine months after. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from ME, USA. Female patient was vaccinated with HEP B (ENGERIX-B) on July 2005, 01. This case was reported by a nurse and described an adult female subject who was vaccinated with hepatitis B vaccine recombinant Engerix B and subsequently tested positive for the hepatitis B antigen. Medical history included renal failure (cause not specified) requiring hemodialysis. The nurse reported that, on June 20 2005, a hepatitis B antigen test was negative. On 7/1/2005 the subject received the 1st dose of Engerix B. The nurse reported that, on 7/4/2005, 3 days after vaccination with Engerix, the pat.Paient has the following illness history - Hemodialysis, Renal failure.. Patient recovered.

HEP B (ENGERIX-B)(produced by GLAXOSMITHKLINE) problem was reported from PA, USA. Female patient was vaccinated with HEP B (ENGERIX-B). This case was reported by a physicians assistant and described an adult subject of unspecified gender who was vaccinated with hepatitis B vaccine recombinant Engerix B and subsequently tested positive for the hepatitis B antigen. The physicians assistant reported that there were four cases of antigenemia detected following the administration of Engerix B, however subject identifiers were not provided. Medical history included renal failure (cause not specified) requiring hemodialysis. On an unspecified date.Paient has the following illness history - Hemodialysis, Renal failure.. Patient recovered.

…………………………………………………………………………………….

< Previous  Showing 61-90 of 330 Next >


Loading

Please Share Your HEP B (ENGERIX-B) Experience, Join the Discussion:
Medical Device Index: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
Source: VAERS
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.We hope you found our information about b>HEP B (ENGERIX-B).